12:00 AM
 | 
Apr 03, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Lorus preclinical data

LOR presented data showing that reduction of ribonucleotide reductase levels following treatment with GTI-2040 was associated with tumor growth reduction, disease stabilization and tumor regression in...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >